Inhibition of PRMT5 by AMI-1 or knockdown of PRMT5 by siRNA in CRC led to the restoration of critical regulatory pathways affecting cell growth, survival, migration and tumor suppressor activity. Here, PRMT5 is linked to neoplasm.